PARP inhibitors—understanding the risk of myelodysplastic syndrome and acute myeloid leukaemia
Publication date: Available online 18 December 2020Source: The Lancet HaematologyAuthor(s): Anna V Tinker
Source: The Lancet Haematology - Category: Hematology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia | Myelodysplastic Syndrome